Artivion’s SVP Jean Holloway sells $425k in stock

Published 12/03/2025, 20:44
Artivion’s SVP Jean Holloway sells $425k in stock

Jean F. Holloway, Senior Vice President and General Counsel at Artivion, Inc. (NYSE:AORT), a medical device company with a market capitalization of approximately $993 million, recently executed a series of stock transactions, according to a recent SEC filing. According to InvestingPro data, the stock is currently showing signs of being oversold, with analyst price targets ranging from $30 to $35. On March 11, Holloway sold 18,020 shares of Artivion’s common stock, generating approximately $425,509. The shares were sold at a weighted average price of $23.6132, with individual sale prices ranging from $23.220 to $23.895.

In a related transaction, Holloway exercised stock options to acquire 19,092 shares at a price of $21.55 per share, amounting to a transaction total of $411,432. These transactions were conducted under a 10b5-1 trading plan established by Holloway in August 2024. Following these transactions, Holloway holds 197,184 shares of the company.

In other recent news, Artivion Inc. reported its fourth-quarter 2024 earnings, revealing a revenue of $97.3 million, which fell short of the forecasted $100.82 million. This shortfall was attributed to a cybersecurity incident that impacted sales by approximately $4.5 million. Despite the revenue miss, Artivion’s adjusted EBITDA for the quarter exceeded expectations, reaching $17.6 million, a 15% increase year-over-year. Analysts from Stifel, Needham, and JMP Securities have adjusted their outlooks on Artivion, with Stifel and Needham lowering their price targets to $30 and $32, respectively, while JMP maintained its $33 target. The cybersecurity breach affected Artivion’s tissue preservation division, which saw an 8% decline year-over-year, and extended lead times for product deliveries. Management anticipates that the effects of the cybersecurity incident will continue into the first quarter of 2025 but expects a recovery in sales growth throughout the year. Artivion projects 2025 revenue to be between $420 million and $435 million, with adjusted EBITDA anticipated to reach between $84 million and $91 million.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.